Excitement over healthcare artificial intelligence (AI) in the scientific and investor communities isn’t translating into enthusiasm from patients and caregivers, according to a report released today by Syneos Health Communications. The report shows that the top two fears patients and caregivers have when it comes to artificial intelligence are lack of human oversight and the potential for machine errors leading to mismanagement of their health.
Over the last five years, more than 300 venture capital and private equity deals have been made to fund experiments in AI for healthcare, more than in any other industry. Much of the discussion has been focused on the potential role of AI in predicting or diagnosing conditions, with conversations led by technologists, scientists or providers. Until now, there’s been a missing component in healthcare’s AI conversation: the voices of patients.
The Syneos Health Communications report, “Artificial Intelligence for Authentic Engagement: Patient Perspectives on Healthcare’s Evolving AI Conversation,” provides what we believe to be the first window into patients’ thought processes as they begin to confront an AI future. It unveils new research from a survey of approximately 800 European and American patients in three disease areas—atrial fibrillation, Type 2 diabetes, breast cancer—and 200 caregivers for people with Parkinson’s disease.[i] The survey results are coupled with additional insight from follow-up focus groups exploring current ideas, expectations and concerns from these patients and caregivers.
Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373
3201 Beechleaf Court
Raleigh, NC 27604-1547